Abstract
As the use of adenoviral vectors in gene therapy protocols increases, there is a corresponding need for rapid, accurate, and reproducible titer methods. Multiple methods currently exist for determining titers of recombinant adenoviral vector, including optical absorbence, electron microscopy, fluorescent focus assay, and the “gold standard” plaque assay. This paper introduces a novel flow cytometric method for direct titer determination that relies on the expression of the green fluorescent protein (GFP), a tracking marker incorporated into several adenoviral vectors. This approach was compared to the plaque assay using 10−4-to 10−6-fold dilutions of a cesium-chloride-purified, GFP expressing adenovirus (AdEasy+GFP+GAL). The two approaches yielded similar titers: 3.25±1.85×109 PFU/mL versus 3.46±0.76×109 green fluorescent units/(gfu/mL). The flow cytometric method is complete within 24 h in contrast to the 7×10 days required by the plaque assay. These results indicate that the GFU/mL is an alternative functional titer method for fluorescent-tagged adenoviral vectors.
Similar content being viewed by others
References
Berkner, K. (1988) Development of adenovirus vectors for the expression of heterologous genes. Biotechniques. 6, 616–624.
Dulver, K. W. (1996) Gene Therapy: A Primer for Physicians, Mary Ann Liebert, Larchmont, NY.
Mitterder, N., March, K.L., and Trapnell, B.C. (1996) Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. Journal of Virology 70, 7498–7509.
Philipson, L. (1961) Adenovirus assay by the fluorescent cell-counting procedure. Virology 15, 263–268.
Lawrence, W.C., and Ginsberg, H.S. (1967) Intracellular uncoating of type 5 adenovirus deoxyribonucleic acid. Journal of Virology 1, 851–867.
Strayer, D.S., Duan, L.-X., Ozaki, I., Milano, J., Bobraski, L.E., and Bagasra, O. (1997) Titering replication-defective virus for use in gene transfer. Biotechniques 2, 447–450.
Zhu, J., Grace, M., Casale, J., Chang, A.T.-I., Musco, M.L., Bordens, R., et al. (1999) Characterization of replication-competent adenovirus isolates from largescale production of a recombinant adenoviral vector. Human Gene Therapy 10, 113–121.
Nyberg-Hoffman, C., Shabram, P., Li, W., Giroux, D., and Aguilar-Cordova, E. (1997) Sensitivity and reproducibility in adenoviral intectious titer determination. Nature Medicine 3, 808–811.
Maizel, J.V., White, D., and Scharff, M.D. (1968) The polypeptide of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7a, and 12. Virology 36, 115–125.
Musco, M.L., Cui, S., Small, D., Nodelman, M., Sugarman, B., and Grace, M. (1998) Comparison of flow cytometry and laser scanning cytometry for the intracellular evaluation of adenoviral infectivity and p53 protein expression in gene therapy. Cytometry 33, 290–296.
Chalfie, M., Tu, Y., Euskirchen, G., Ward, W.W., and Prasher, D.C. (1994) Green fluorescent protein as a marker for gene expression. Science 263, 802–805.
Inouye, S., and Tsuji, F.I. (1994) Aequora green fluorescent protein. Expression of the gene and fluorescent characteristics of the recombinant protein. FEBS Letters 341, 277–280.
He, T.-C., Zhou, S., da Costa, L.T., Yu, J., Kinzler, K.W., and Vogelstein, B. (1998) A simplified system for generating recombinant adenoviruses. Proceedings of the National Academy of Science USA 95, 2509–2514.
Cheng, L., Fu, J., Tsukamoto, A., and Hawley, R.G. Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cells. Nature Biotechnology 14, 606–609.
Subramanian, S., and Srienc, F. (1996) Quantitative analysis of transient gene expression in mammalian cells using the green fluorescent protein. Journal of Biotechnology 49, 137–151.
Levy, J.P., Muldoon, R.R., Zolotukhin, S., and Link, C.J. Jr. (1996) Retroviral transfer and expression of a humanized, red-shifted green fluorescent protein into human tumor cells. Nature Biotechnology 14, 610–614.
Dominguez, J., del Mar Lorenzo, M., and Blasco, R. (1998) Green fluorescent protein expressed by a recombinant vaccinia virus permits early detection of infected cells by flow cytometry. Journal of Immunological Methods 220, 115–121.
Ropp, J.D., Donahue, C.J., Wolfgang-Kimball, D., Hooley, J.J., Chin, J.Y.W., Hoffman, R.A., Cuthbertson, R.A., et al. (1995) Aequora green fluorescent protein analysis by flow cytometry. Cytometry 21, 309–317.
Ropp, J.D., Donahue, C.J., Wolfgang-Kimball, D., Hooley, J.J., Chin, J.Y.W., Cuthbertson, R.A., et al. (1996) Aequora green fluorescent protein: simultaneous analysis of wild-type and blue-fluorescing mutant by flow cytometry. Cytometry 24, 284–288.
Lybarger, L., Dempsey, D., Franek, K.J., and Chervenak, R. (1996) Rapid generation and flow cytometric analysis of stable GFP-expressing cells. Cytometry 25, 211–220.
Graham, F.L., Smiley, J., Russell, W.C., and Nairn, R. (1977) Characteristics of a human cell line transformed by DNA from human adenovirus Type 5. Journal of General Virology 36, 59–74.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hitt, D.C., Booth, J.L., Dandapani, V. et al. A flow cytometric protocol for titering recombinant adenoviral vectors containing the green fluorescent protein. Mol Biotechnol 14, 197–203 (2000). https://doi.org/10.1385/MB:14:3:197
Issue Date:
DOI: https://doi.org/10.1385/MB:14:3:197